Tender detail

Non-exclusive rebate agreement for medicines containing cladribine for 1 December 2026 to 30 November 2027

Summary

DAK-Gesundheit intends to conclude a non-exclusive rebate agreement for medicines containing cladribine (ATC L04AA40). The agreement will run from 1 December 2026 to 30 November 2027 and may be extended once for 12 months. It will end automatically when an exclusive agreement takes effect.

Reference number
4d2a2bb0-d99a-4fb1-b5d8-19fdeca364fd
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-10-05
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.